Ab Index-Nr. 614-002-00-X

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
614-002-00-Xsalts of nicotineAcute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Chronic 2
H330
H310
H300
H411
GHS06
GHS09
Dgr
H330
H310
H300
H411
  A
614-003-00-5strychnine200-319-757-24-9Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
   
614-004-00-0salts of strychnineAcute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410
  A
614-005-00-6colchicine200-598-564-86-8Muta. 1B
Acute Tox. 2 *
H340
H300
GHS06
GHS08
Dgr
H340
H300
   
614-006-00-1brucine;
2,3-dimethoxystrychnine
206-614-7357-57-3Acute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Chronic 3
H330
H300
H412
GHS06
Dgr
H330
H300
H412
   
614-007-00-7brucine sulphate; [1]
brucine nitrate; [2]
strychnidin-10-one,
2,3-dimethoxy-, mono
[(R)-1-methylheptyl
1,2-benzenedicarboxylate]; [3]
strychnidin-10-one,
2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-
1,2-benzenedicarboxylate (1:1) [4]
225-432-9 [1]
227-317-9 [2]
269-439-5 [3]
269-710-8 [4]
4845-99-2 [1]
5786-97-0 [2]
68239-26-9 [3]
68310-42-9 [4]
Acute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Chronic 3
H330
H300
H412
GHS06
Dgr
H330
H300
H412
  A
614-008-00-2aconitine206-121-7302-27-2Acute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
   
614-009-00-8salts of aconitineAcute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
  A
614-010-00-3atropine200-104-851-55-8Acute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
   
614-011-00-9salts of atropineAcute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
  A
614-012-00-4hyoscyamine202-933-0101-31-5Acute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
   
614-013-00-Xsalts of hyoscyamineAcute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
  A
614-014-00-5hyoscine200-090-351-34-3Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
H330
H310
H300
GHS06
Dgr
H330
H310
H300
   
614-015-00-0salts of hyoscineAcute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
H330
H310
H300
GHS06
Dgr
H330
H310
H300
  A
614-016-00-6pilocarpine202-128-492-13-7Acute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
   
614-017-00-1salts of pilocarpineAcute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
  A
614-018-00-7papaverine200-397-258-74-2Acute Tox. 4 (*)H302GHS07
Wng
H302   
614-019-00-2salts of papaverineAcute Tox. 4 (*)H302GHS07
Wng
H302  A
614-020-00-8physostigmine200-332-857-47-6Acute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
   
614-021-00-3salts of physostigmineAcute Tox. 2 (*)
Acute Tox. 2 (*)
H330
H300
GHS06
Dgr
H330
H300
  A
614-022-00-9digitoxin200-760-571-63-6Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
H331
H301
H373 (*)(*)
GHS06
GHS08
Dgr
H331
H301
H373 (*)(*)
   
614-023-00-4ephedrine206-080-5299-42-3Acute Tox. 4 (*)H302GHS07
Wng
H302   
614-024-00-Xsalts of ephedrineAcute Tox. 4 (*)H302GHS07
Wng
H302  A
614-025-00-5ouabain211-139-3630-60-4Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
H331
H301
H373 (*)(*)
GHS06
GHS08
Dgr
H331
H301
H373 (*)(*)
   
614-026-00-0strophantin-K234-239-911005-63-3Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
H331
H301
H373 (*)(*)
GHS06
GHS08
Dgr
H331
H301
H373 (*)(*)
   
614-027-00-6bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-
D-glucopyranosyloxy)-8,14-
dihydroxy-, (3β, 6β)-;
red squill;
scilliroside
208-077-4507-60-8Acute Tox. 2 (*)H300GHS06
Dgr
H300   
614-028-00-1reaction mass of:
2-ethylhexyl mono-D-
glucopyranoside;
2-ethylhexyl di-D-glucopyranoside
414-420-0Eye Dam. 1H318GHS05
Dgr
H318   
614-029-00-7constitutional isomers of penta-O-allyl-β-D-
fructofuranosyl-α-D-
glucopyranoside;
constitutional isomers of hexa-O-allyl-β-D-
fructofuranosyl-α-D-
glucopyranoside;
constitutional isomers of hepta-O-allyl-β-D-
fructofuransoyl-α-D-
glucopyranoside
419-640-068784-14-5Acute Tox. 4 (*)H302GHS07
Wng
H302   
615-001-00-7methyl isocyanate210-866-3624-83-9Flam. Liq. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Resp. Sens. 1
Skin Sens. 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H225
H361d ***
H330
H311
H301
H334
H317
H335
H315
H318
GHS02
GHS06
GHS05
GHS08
Dgr
H225
H361d ***
H330
H311
H301
H334
H317
H335
H315
H318
   
615-002-00-2methyl isothiocyanate209-132-5556-61-6Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H301
H314
H317
H410
   
615-003-00-8thiocyanic acid207-337-4463-56-9Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
EUH032  
615-004-00-3salts of thiocyanic acid, with the exception of
those specified elsewhere in this Annex
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
EUH032 A
615-005-00-94,4´-methylenediphenyl diisocyanate;
diphenylmethane-4,4´-diiso-
cyanate; [1]
2,2´-methylenediphenyl diisocyanate;
diphenylmethane-2,2´-diiso-
cyanate; [2]
o-(p-isocyanatobenzyl)phenyl isocyanate;
diphenylmethane-2,4´-diiso-
cyanate; [3]
methylenediphenyl diisocyanate [4]
202-966-0 [1]
219-799-4 [2]
227-534-9 [3]
247-714-0 [4]
101-68-8 [1]
2536-05-2 [2]
5873-54-1 [3]
26447-40-5 [4]
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H351
H332
H373 **
H319
H335
H315
H334
H317
GHS08
GHS07
Dgr
H351
H332
H373 **
H319
H335
H315
H334
H317
 Eye Irrit. 2;
H319: C ≥ 5 %
Skin Irrit. 2;
H315: C ≥ 5 %
Resp. Sens. 1;
H334: C ≥
0,1 %
STOT SE 3;
H335: C ≥ 5 %
C
2
615-006-00-42-methyl-m-phenylene diisocyanate;
toluene-2,4-di-isocyanate; [1]
4-methyl-m-phenylene diisocyanate;
toluene-2,6-di-isocyanate; [2]
m-tolylidene diisocyanate;
toluene-diisocyanate [3]
202-039-0 [1]
209-544-5 [2]
247-722-4 [3]
91-08-7 [1]
584-84-9 [2]
26471-62-5 [3]
Carc. 2
Acute Tox. 2 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H351
H330
H319
H335
H315
H334
H317
H412
GHS06
GHS08
Dgr
H351
H330
H319
H335
H315
H334
H317
H412
 Resp. Sens. 1;
H334: C ≥ 0,1 %
C
615-007-00-X1,5-naphthylene diisocyanate221-641-43173-72-6Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Aquatic Chronic 3
H332
H319
H335
H315
H334
H412
GHS08
GHS07
Dgr
H332
H319
H335
H315
H334
H412
   
615-008-00-53-isocyanatomethyl-3,5,5-
trimethylcyclohexyl isocyanate;
isophorone di-isocyanate
223-861-64098-71-9Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2
H331
H319
H335
H315
H334
H317
H411
GHS06
GHS08
GHS09
Dgr
H331
H319
H335
H315
H334
H317
H411
 (*)
Resp. Sens. 1;
H334: C ≥ 0,5 %
Skin Sens.1;
H317: C ≥ 0,5 %
2
615-009-00-04,4'-methylenedi(cyclohexyl isocyanate);
dicyclohexylmethane-4,4'-di-isocyanate
225-863-25124-30-1Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H331
H319
H335
H315
H334
H317
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
H317
 (*)
Resp. Sens. 1;
H334: C ≥ 0,5 %
Skin Sens. 1;
H317: C ≥ 0,5 %
2
615-010-00-62,2,4-trimethylhexamethy-
lene-1,6-di-isocyanate; [1]
2,4,4-trimethylhexamethy-
lene-1,6-di-isocyanate [2]
241-001-8 [1]
239-714-4 [2]
16938-22-0 [1]
15646-96-5 [2]
Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H331
H319
H335
H315
H334
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
 (*)
Resp. Sens. 1;
H334: C ≥ 0,5 %
Skin Sens. 1;
H317: C ≥ 0,5 %
C 2
615-011-00-1hexamethylene-di-isocyanate212-485-8822-06-0Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H331
H319
H335
H315
H334
H317
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
H317
 (*)
Resp. Sens. 1;
H334: C ≥ 0,5 %
Skin Sens. 1;
H317: C ≥ 0,5 %
2
615-012-00-74-isocyanatosulphonyltoluene;
tosyl isocyanate
223-810-84083-64-1Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
EUH014Eye Irrit.; H319: C ≥ 5%
STOT SE 3;
H335: C ≥ 5 %
Skin Irrit. 2;
H315: C ≥ 5 %
 
bis 30.11.2018:
615-013-00-2
cyanamide;
carbanonitril
206-992-3420-04-2Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H301
H312
H319
H315
H317
GHS06
Dgr
H301
H312
H319
H315
H317
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
615-013-00-2
Cyanamid;
Carbamonitril
206-992-3420-04-2Carc. 2
Repr. 2
Acute Tox. 3
Acute Tox. 3
STOT RE 2
Skin Corr. 1
Skin Sens. 1
Eye Dam. 1
Aquatic Chronic 3
H351
H361fd
H311
H301
H373
(Schilddrüse)
H314
H317
H318
H412
GHS08
GHS06
GHS05
Dgr
H351
H361fd
H311
H301
H373
(Schilddrüse)
H314
H317
H412
   
615-014-00-8tris(1-dodecyl-3-methyl-2-
phenylbenzimida-
zolium)hexacyanoferrate
7276-58-6Acute Tox. 4 (*)H302GHS07
Wng
H302   
615-015-00-31,7,7-trimethylbicyc-
lo(2,2,1)hept-2-yl thiocya-
natoacetate;
isobornyl thiocyanoacetate
204-081-5115-31-1Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
615-016-00-9potassium cyanate209-676-3590-28-3Acute Tox. 4 (*)H302GHS07
Wng
H302   
615-017-00-4calcium cyanamide205-861-8156-62-7Acute Tox. 4 (*)
STOT SE 3
Eye Dam. 1
H302
H335
H318
GHS05
GHS07
Dgr
H302
H335
H318
   
615-018-00-X2-(2-butoxyethoxy)ethyl thiocyanate203-985-7112-56-1Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 3 (*)
H226
H311
H301
GHS02
GHS06
Dgr
H226
H311
H301
   
615-019-00-5dicyclohexylcarbodiimide208-704-1538-75-0Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
H311
H302
H318
H317
GHS06
GHS05
Dgr
H311
H302
H318
H317
   
615-020-00-0methylene dithiocyanate228-652-36317-18-6Acute Tox. 2 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
H330
H301
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H330
H301
H314
H317
H400
   
615-021-00-61,3,5-tris(oxiranylmethyl)-
1,3,5-triazine-2,4,6(1H,3H,5H)-
trione;
TGIC
219-514-32451-62-9Muta. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H340
H331
H301
H373 (*)(*)
H318
H317
H412
GHS06
GHS08
GHS05
Dgr
H340
H331
H301
H373 (*)(*)
H318
H317
H412
   
615-022-00-1methyl 3-isocyanatosulfo-
nyl-2-thiophenecarboxylate
410-550-779277-18-2STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
H373 **
H334
H317
GHS08
Dgr
H373 **
H334
H317
EUH014  
615-023-00-72-(isocyanatosulfonylmethyl)benzoic acid methyl ester;
(alt.):methyl 2-(isocya-
natosulfonylmethyl)benzoate
410-900-983056-32-0Flam. Liq. 3
Muta. 2
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Resp. Sens. 1
H226
H341
H332
H373 (*)(*)
H318
H334
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H341
H332
H373 (*)(*)
H318
H334
EUH014  
615-024-00-22-phenylethylisocyanate413-080-01943-82-4Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2
H331
H302
H314
H334
H317
H411
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H314
H334
H317
H411
   
615-025-00-84,4'-ethylidenediphenyl dicyanate405-740-147073-92-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H373 (*)(*)
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H332
H302
H373 (*)(*)
H318
H410
   
615-026-00-34,4'-methylenebis(2,6-
dimethylphenyl cyanate)
405-790-4101657-77-6Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
615-028-00-4ethyl 2-(isocyanato-
sulfonyl)benzoate
410-220-277375-79-2Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H302
H373 **
H318
H334
H317
GHS05
GHS08
GHS07
Dgr
H302
H373 **
H318
H334
H317
EUH014  
615-029-00-X2,5-bis-isocyanatomethyl-
bicyclo[2.2.1]heptane
411-280-2Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H330
H302
H314
H334
H317
H412
GHS06
GHS08
GHS05
Dgr
H330
H302
H314
H334
H317
H412
   
615-030-00-5alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified else where in this AnnexAcute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
  A
615-031-00-0thallium thiocyanate222-571-73535-84-0Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2
Aquatic Chronic 2
H330
H300
H312
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H312
H373 **
H411
   
615-032-00-6metal salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexAcute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
  A
615-033-00-1reaction product of diphenyl-
methanediisocyanate, octylamine, oleylamine and cyclohexylamine
(1:1.58:0.32:0.097)
430-980-9Aquatic Chronic 4H413H413   
615-034-00-7reaction product of diphenylmethane-
diisocyanate, octylamine,
4-ethoxyaniline and ethylenediamine
(1:0,37:1,53:0,05)
430-750-8Aquatic Chronic 4H413H413   
615-035-00-2reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)430-930-6122886-55-9Aquatic Chronic 4H413H413   
615-036-00-8reaction product of diphenyl-
methanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)
430-940-0Aquatic Chronic 4H413H413   
615-037-00-3reaction product of diphenyl-
methanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)
430-950-5Aquatic Chronic 4H413H413   
615-038-00-9reaction product of toluenedi-
isocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)
430-960-1Aquatic Chronic 4H413H413   
615-039-00-4reaction product of
diphenylmethanediisocyanate,
toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diiso-
cyanate), octylamine,
oleylamine and 4-ethoxyaniline
(molar ratio 3.88:1:6.38:0.47:2.91)
430-970-4Aquatic Chronic 4H413H413   
615-044-00-14-chlorophenylisocyanate203-176-9104-12-1Acute Tox. 2 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H335
H315
H318
H334
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H330
H302
H335
H315
H318
H334
H410
   
615-045-00-74,4´-methylene bis(3-chloro-
2,6-diethylphenylisocyanate)
420-530-1Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Dgr
H334
H317
H413
   
616-001-00-XN,N-dimethylformamide;
dimethyl formamide
200-679-568-12-2Repr. 1B (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
H360D
(*)(*)(*)
H332
H312
H319
GHS08
GHS07
Dgr
H360D
(*)(*)(*)
H332
H312
H319
   
616-002-00-52-fluoroacetamide211-363-1640-19-7Acute Tox. 2 (*)
Acute Tox. 3 (*)
H300
H311
GHS06
Dgr
H300
H311
   
616-003-00-0acrylamide;
prop-2-enamide
201-173-779-06-1Carc. 1B
Muta. 1B
Repr. 2 (*)
Acute Tox. 3
STOT RE 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H350
H340
H361f
(*)(*)(*)
H301
H372 (*)(*)
H332
H312
H319
H315
H317
GHS06
GHS08
Dgr
H350
H340
H361f
(*)(*)(*)
H301
H372 (*)(*)
H332
H312
H319
H315
H317
  D
616-004-00-6allidochlor (ISO);
N,N-diallylchloroacetamide
202-270-793-71-0Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H312
H302
H319
H315
H411
GHS07
GHS09
Wng
H312
H302
H319
H315
H411
   
616-005-00-1chlorthiamid (ISO);
2,6-dichloro (thiobenzamide)
217-637-71918-13-4Acute Tox. 4 (*)H302GHS07
Wng
H302   
bis 30.11.2018:
616-006-00-7
dichlofluanid (ISO);
N-dichlorofluoromethylthio-
N´,N´-dimethyl-N-phenyl-
sulfamide
214-118-71085-98-9Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H332
H319
H317
H400
GHS07
GHS09
Wng
H332
H319
H317
H400
 M = 10 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-006-00-7
Dichlofluanid (ISO);
N-[(Dichlorofluoromethyl)thio]-
N´,N´-dimethyl-N-phenyl-
sulfamid
214-118-71085-98-9Acute Tox. 4
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H332
H319
H317
H400
GHS07
GHS09
Wng
H332
H319
H317
H400
 M = 10 
616-007-00-2diphenamid (ISO);
N,N-dimethyl-2,2-diphenyl-
acetamide
213-482-4957-51-7Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
616-008-00-8propachlor (ISO);
2-chloro-N-isopropylacetanilide;
α-chloro-N-isopropyl-
acetanilide
217-638-21918-16-7Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H317
H400
H410
GHS07
GHS09
Wng
H302
H319
H317
H410
   
616-009-00-3propanil (ISO);
3´,4´-dichloropropionanilide
211-914-6709-98-8Acute Tox. 4 *
Aquatic Acute 1
H302
H400
GHS07
GHS09
Wng
H302
H400
 M = 10 
616-010-00-9tosylchloramide sodium204-854-7127-65-1Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1
H302
H314
H334
GHS08
GHS05
GHS07
Dg
H302
H314
H334
EUH031  
bis 28.02.2018
616-011-00-4
N,N-dimethylacetamide204-826-4127-19-5Repr. 1B (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H360D
(*)(*)(*)
H332
H312
GHS08
GHS07
Dgr
H360D
(*)(*)(*)
H332
H312
 Repr. 1B; H360D:
C ≥ 5%
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-011-00-4
N,N-Dimethylacetamid204-826-4127-19-5Repr. 1B
Acute Tox. 4*
Acute Tox. 4*
H360D***
H332
H312
GHS08
GHS07
Dgr
H360D***
H332
H312
   
616-012-00-XN-(dichlorofluoromethyl-
thio)phthalimide; N-(fluorodichloromethyl-
thio)phthalimide
211-952-3719-96-0Skin Irrit. 2 H315GHS07
Wng
H315